In another study of patients with stage I to III breast cancer, Black patients had significantly higher rates of TP53 mutations and significantly lower rates of PIK3CA mutations compared to White patients, though no differences were seen in GATA3 mutations. This evidence concerns the gene GATA3 and breast cancer.